Compugen (CGEN)
2.42
0.00 (0.00%)
Upcoming Events
Latest Headlines
Compugen to Participate in BTIG Biotechnology Conference 2026
July 21, 2026 7:00 AM - PR NewsWire
Compugen to Release Second Quarter 2026 Results on Monday, August 3, 2026
July 20, 2026 7:00 AM - PR NewsWire
Form 4 COMPUGEN LTD For: Jul 09 Filed by: Levine Zurit
July 13, 2026 4:02 PM - SEC Filing
Compugen presents COM701 ovarian cancer trial poster at ESMO
June 18, 2026 7:00 AM - StreetInsider
Compugen Presents a Trial-in-Progress Poster on the MAIA-ovarian Adaptive Platform Trial at ESMO Gynaecological Cancers Congress
June 18, 2026 7:00 AM - PR NewsWire
Compugen to present ovarian cancer trial data at ESMO congress
June 11, 2026 7:00 AM - StreetInsider
Compugen to Present Phase 1 MAIA-Ovarian Trial-in-Progress Poster at ESMO Gynaecological Cancers Congress 2026
June 11, 2026 7:00 AM - PR NewsWire
Form EFFECT COMPUGEN LTD
June 9, 2026 6:05 AM - SEC Filing
Compugen to Participate in Jones Trading Fireside Chat Series with Leaders in AI/ML-based Drug Development
June 8, 2026 7:00 AM - PR NewsWire
H.C. Wainwright Reiterates Buy Rating on Compugen (CGEN)
June 4, 2026 6:42 AM - StreetInsider
Form F-3 COMPUGEN LTD
May 18, 2026 4:03 PM - SEC Filing
Compugen (CGEN) Misses Q1 EPS by 1c
May 18, 2026 7:02 AM - StreetInsider
Form 6-K COMPUGEN LTD For: May 18
May 18, 2026 7:00 AM - SEC Filing
Compugen Reports First Quarter 2026 Results
May 18, 2026 7:00 AM - PR NewsWire
Compugen to Participate in 2026 Stifel Virtual Targeted Oncology Forum
May 12, 2026 7:00 AM - PR NewsWire
Compugen to Release First Quarter 2026 Results on Monday, May 18, 2026
May 4, 2026 7:00 AM - PR NewsWire
Form 4 COMPUGEN LTD For: Apr 24 Filed by: Levine Zurit
April 27, 2026 4:03 PM - SEC Filing
Form 4 COMPUGEN LTD For: Apr 24 Filed by: Ophir Eran
April 27, 2026 4:02 PM - SEC Filing
Form 144 COMPUGEN LTD Filed by: Ophir Eran
April 27, 2026 6:53 AM - SEC Filing
Form 144 COMPUGEN LTD Filed by: Levine Zurit
April 27, 2026 6:41 AM - SEC Filing
Full Article List
